Package Leaflet:information for the patient
Anagrelida Stada 0.5mg hard capsules EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Anagrelida Stada contains the active substance anagrelide.
Anagrelide is a medicine that interferes with the production of platelets. It reduces the number of platelets produced by the bone marrow, which leads to a reduction in the platelet count in the blood to a more normal level. For this reason, it is used to treat patients with essential thrombocythemia.
Essential thrombocythemia is a condition that occurs when the bone marrow produces too many of the blood cells known as platelets. A high number of platelets in the blood can cause serious problems with blood circulation and clotting.
Do not take Anagrelida Stada
Warnings and precautions
Consult your doctor before starting to take anagrelide:
In combination with acetylsalicylic acid(a substance present in many medicines used to relieve pain and lower fever, as well as to prevent blood clotting), there is a greater risk of major bleeding (bleeding) (see section "Other medicines and Anagrelida Stada").
While you are being treated with anagrelide, you should take the exact dose prescribed by your doctor. Do not stop taking the medicine without informing your doctor first. Do not stop taking this medicine suddenly without consulting your doctor. Stopping the medicine abruptly can increase the risk of a stroke.
The signs and symptoms of a stroke can include sudden numbness or weakness in the face, arm, or leg, especially on one side of the body, sudden confusion, difficulty speaking or understanding speech, sudden difficulty seeing with one or both eyes, sudden difficulty walking, dizziness, loss of balance or coordination, and sudden severe headache with no known cause. Please consult your doctor immediately.
Children and adolescents
Information on the use of anagrelide in children and adolescents is limited, and therefore, this medicine should be used with caution.
Other medicines and Anagrelida Stada
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Tell your doctor if you are taking any of the following medicines:
If used together, it may be that either anagrelide or these medicines do not work properly.
Consult your doctor or pharmacist if you have any doubts.
Pregnancy and breastfeeding
Consult your doctor if you are pregnant or plan to become pregnant. If you are pregnant, you should not take anagrelide. Women who may become pregnant should ensure they take effective contraceptive measures while taking anagrelide. Consult your doctor if you need advice on contraceptives.
Consult your doctor if you are breastfeeding or plan to breastfeed your child. You should not take anagrelide while breastfeeding. If you are taking anagrelide, you should stop breastfeeding.
Driving and using machines
Some patients who were taking anagrelide have reported symptoms of dizziness. Do not drive or operate machinery if you feel dizzy.
Anagrelida Stadacontains lactose and sodium
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
This medicine contains less than 23 mg of sodium (1 mmol) per capsule; this is, essentially, "sodium-free".
Follow the instructions for administration of this medicine exactly as prescribed by your doctor. If you are unsure, consult your doctor or pharmacist again.
The amount of anagrelide that different patients can take may vary, as this depends on the condition. Your doctor will prescribe the most suitable dose for your case.
The normal initial dose of anagrelide is 1 mg. This dose is taken with one 0.5 mg capsule twice a day for at least one week. After this period, your doctor may increase or decrease the number of capsules you should take until they find the dose that best suits your case and treats the condition most effectively.
The capsules should be swallowed whole with a glass of water. Do not crush the capsules or dissolve the contents in a liquid. You can take the capsules with food, after meals, or on an empty stomach. It is recommended to take the capsule(s) always at the same time.
Do nottake more or fewer capsules than your doctor has recommended. Do notstop taking the medicine without informing your doctor first. You should not stop taking this medicine suddenly without consulting your doctor.
Your doctor will tell you to have regular blood tests to check if the medicine is working and if your liver and kidneys are working properly.
If you take more Anagrelida Stada than you should
If you take more anagrelide than you should or if someone else has taken this medicine, inform your doctor or pharmacist immediately. You should show them the anagrelide packaging.
If you forget to take Anagrelida Stada
Take the capsules as soon as you remember. Take the next dose at the usual time. Do not take a double dose to make up for forgotten doses.
Empty section
Like all medicines, this medicine can cause side effects, although not everybody gets them. If this worries you, consult your doctor.
Serious side effects:
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
If you notice any of these side effects, contact your doctor immediately.
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
The doctor may perform blood tests that could indicate an increase in liver enzymes.
Rare(may affect up to 1 in 1,000 people)
The following side effects have been reported, but the exact frequency is unknown(the frequency cannot be estimated from the available data)
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Agency's website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label of the bottle or carton after EXP. The expiry date refers to the last day of the month shown.
Do not store above 30°C
Store in the original packaging to protect from light and moisture.
If your doctor stops the treatment, do not keep the leftover capsules unless the doctor tells you to.
Medicines should not be disposed of via wastewater or household waste. Return the packaging and any unused medicine to a pharmacy for disposal. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Anagrelida Stada
The active substance is anagrelide. Each capsule contains 0.5 mg of anagrelide (as anagrelide hydrochloride monohydrate).
The other ingredients are:
Capsule content: lactose monohydrate, sodium croscarmellose, povidone (K29/32), lactose, microcrystalline cellulose, magnesium stearate.
Capsule shell: gelatin, titanium dioxide (E171).
Appearance of the product and packaging
Anagrelida 0.5 mg is presented in the form of hard capsules (size 4) opaque white. The capsules contain white or almost white powder.
The capsules are presented in bottles with child-resistant closures and desiccant, containing 42 or 100 hard capsules.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer Marketing authorization holder Laboratorio STADA, S.L. Frederic Mompou, 5 08960 Sant Just Desvern (Barcelona) Spain | |
Manufacturer Synthon Hispania, S.L. c/Castelló, 1 Pol. Las Salinas 08830 Sant Boi de Llobregat (Barcelona) Spain or Synthon BV Microweg, 22 6545 CM Nijmegen Netherlands or STADA Arzneimittel AG Stadastrasse, 2 – 18 61118 Bad Vilbel Germany or Centrafarm Services B.V. Van de Reijtstraat 31-E, 4814 NE Breda Netherlands |
This medicine is authorized in the Member States of the European Economic Area under the following names:
Czech Republic | Anagrelid Stada |
Denmark | Anagrelide Stada |
Spain | Anagrelida Stada 0.5 mg hard capsules EFG |
Finland | Anagrelide Stada 0.5 mg capsule, hard |
France | Anagrelide EG 0.5 mg, capsule |
Croatia | Anagrelid Stada 0.5 mg hard capsules |
Hungary | Anagrelide Stada |
Netherlands | Anagrelide CF 0.5 mg, hard capsules |
Poland | Anagrelide Stada |
Sweden | Anagrelide Stada 0.5 mg capsule, hard |
Slovenia | Anagrelid Stada 0.5 mg hard capsules |
Slovakia | Anagrelid Stada |
Date of last revision of this leaflet:September 2022
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ANAGRELIDE STADA 0.5 mg HARD CAPSULES – subject to medical assessment and local rules.